Prediction of neuroleptic effects of CI-686 based on quantitative pharmaco-electroencephalography: drug profiles and dose response curves based on computerized cerebral bio-potentials.
D000328:Adult; D001578:Benzopyrans / Q000009:adverse effects / Q000494:pharmacology*; D001702:Biopharmaceutics; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002839:Chromans; D002986:Clinical Trials as Topic; D003201:Computers; D004123:Dimethylamines / Q000009:adverse effects / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D013997:Time Factors
D001578:Benzopyrans; D002839:Chromans; D004123:Dimethylamines; D010919:Placebos; C006122:trebenzomine